Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioAge Labs, Inc. - Common Stock
(NQ:
BIOA
)
9.220
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioAge Labs, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
BioAge Labs, Inc. Being Investigated on Behalf of BioAge Labs, Inc. Investors. Contact Levi & Korsinsky For Details
December 16, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - BIOA
December 16, 2024
Via
ACCESSWIRE
Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - BIOA
December 16, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Encourages Stockholder Participation
December 16, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - BIOA
December 16, 2024
Via
ACCESSWIRE
Did BioAge Labs, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- BIOA
December 16, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - BIOA
December 15, 2024
Via
ACCESSWIRE
Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into BioAge Labs Inc For Securities Fraud
December 15, 2024
Via
ACCESSWIRE
Did BioAge Labs, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - BIOA
December 15, 2024
Via
ACCESSWIRE
ATTENTION BioAge Labs, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
December 15, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. (BIOA) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
December 14, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Shareholder Participation
December 14, 2024
Via
ACCESSWIRE
An Investigation Has Commenced on Behalf of BioAge Labs, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your BIOA Losses.
December 13, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - BIOA
December 13, 2024
Via
ACCESSWIRE
Investors With Losses Are Invited To Join The Schall Law Firm's Inquiry Into BioAge Labs Inc For Securities Fraud
December 13, 2024
Via
ACCESSWIRE
Levi & Korsinsky Reminds Shareholders of an Investigation into BioAge Labs, Inc. (BIOA) Regarding Potential Securities Fraud Allegations
December 13, 2024
Via
ACCESSWIRE
Shareholders that lost money on BioAge Labs, Inc. (BIOA) should contact Levi & Korsinsky about Securities Fraud Investigation - BIOA
December 13, 2024
Via
ACCESSWIRE
Investors who lost money on BioAge Labs, Inc. should contact Levi & Korsinsky about an ongoing investigation - BIOA
December 12, 2024
Via
ACCESSWIRE
ATTENTION BIOA SHAREHOLDERS: Investors who lost money on BioAge Labs, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
December 12, 2024
Via
ACCESSWIRE
BioAge Labs Inc. Is Being Investigated For Violating Securities Laws And The Schall Law Firm Encourages Shareholder Participation
December 12, 2024
Via
ACCESSWIRE
Levi & Korsinsky Reminds Shareholders of an Investigation into BioAge Labs, Inc. (BIOA) Regarding Potential Securities Fraud Allegations
December 12, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Being Investigated on Behalf of BioAge Labs, Inc. Investors. Contact Levi & Korsinsky For Details
December 12, 2024
Via
ACCESSWIRE
Levi & Korsinsky Announces an Investigation on Behalf of BioAge Labs, Inc. (BIOA) Shareholders Who May Have Been Affected by Fraud
December 12, 2024
Via
ACCESSWIRE
BIOA Investors Have Opportunity to Join BioAge Labs, Inc. Securities Fraud Investigation with the Schall Law Firm
December 10, 2024
From
The Schall Law Firm
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 09, 2024
Via
Benzinga
Crude Oil Gains 2%; BioAge Labs Shares Plunge
↗
December 09, 2024
Via
Benzinga
Nasdaq Down Over 100 Points; US Wholesale Inventories Rise By 0.2%
↗
December 09, 2024
Via
Benzinga
Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday
↗
December 09, 2024
Via
Benzinga
BioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
December 09, 2024
Via
Benzinga
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns
↗
December 09, 2024
BioAge Labs halts STRIDES Phase 2 trial of azelaprag after liver enzyme elevations, plans further analysis with updates expected in Q1 2025.
Via
Benzinga
Topics
Initial Public Offering
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today